ANPAC Bio-Medical launching new facility in California.
Anpac Bio in the News

Northwestern’s Dr. Lee Shulman Joins Anpac Bio Technical Advisory Board

SACRAMENTO, Calif., Oct. 23, 2018  -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation, Anpac Bio-Medical Science Company (Anpac Bio), announced today that Northwestern University's Dr. Lee P. Shulman, MD, FACMG, FACOG, has joined Anpac Bio's Technical Advisory Board (TAB). It was due to Dr. Shulman's extensive, award-winning research ...

Anpac Bio & UCD Vet Med in Clinical Trial Studying ‘CDA’ Liquid Biopsy Tech for Canine Cancer Screening

Technical Advisory Board Member John Reddington, DVM, PhD & Biosciences Leader to Support New Anpac Bio Animal Care R&D DAVIS, Calif., Oct. 3, 2018 -- The University of California, Davis, School of Veterinary Medicine (UCDSVM) is currently conducting a formal clinical research trial studying Anpac Bio-Medical Science Company's "Cancer Differentiation Analysis" (CDA) ...

Anpac Bio & UC Davis Names 2018 ‘Anpac Bio Innovation & Entrepreneurship Scholars’

Fellowships Fund University of California Entrepreneurship SACRAMENTO, Calif.--(BUSINESS WIRE)--Anpac Bio-Medical Science Company, and the University of California, Davis Mike and Renee Child Institute for Innovation and Entrepreneurship (UCDMRCIIE) selected five accomplished, University of California (UC) scientists to be the 2018 “Anpac Bio-Medical Innovation & Entrepreneurship Scholars” (ABIES); ...

Anpac Bio Increases Global Ranking by Setting Industry-High Liquid Biopsy Patent Milestones: 101 Issued and Over 200 Filed Worldwide

SACRAMENTO, Calif., Sept. 6, 2018 -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation, Anpac Bio-Medical Science Company (Anpac Bio), announced today the organization has surpassed two significant, biotechnology industry milestones: earning 101 patents issued; and filing over 200 patents in 20 countries worldwide. All patents related to ...

Anpac Bio Recognizes 30% Valuation Increase Upon Signing New Customers: 16th and 17th Global Fortune 500 Companies & International Insurance Provider

SACRAMENTO, Calif., July 25, 2018 -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation, Anpac Bio-Medical Science Company, announced the company's valuation leapt nearly 30% immediately following news reports that Anpac Bio successfully secured its 16th and 17th global Fortune 500 companies, as well as a respected international insurance provider, ...

Anpac Bio CMO Drisha Leggitt Named 2018 Leukemia & Lymphoma Society ‘Woman of the Year’

SACRAMENTO, Calif., May 15, 2018  -- Announced before 600+ corporate and health leaders from Kaiser Permanente, Sutter Health, Dignity Health, and the University of California health systems; the Leukemia and Lymphoma Society (LLS) in Greater Sacramento named, Drisha Leggitt, Chief Marketing Officer (CMO) of international life sciences corporation Anpac Bio-Medical Science Company its 2018, "Woman ...

Anpac Bio Receives Exceptional Reimbursement Validation: Revenue in Insurance Sector Surges

Anpac Bio Receives Exceptional Reimbursement Validation Revenue in Insurance Sector Surges SACRAMENTO, CA | April 23, 2018 - Anpac Bio-Science Co., Ltd. ("Anpac Bio" hereafter), an international life science company with operations in both Asia and the US, announced today, that it recognized a 386% growth ...

Super Model-Turned-Super Mogul Kathy Ireland Interviews Anpac Bio CEO For ‘Worldwide Business’

Super Model-Turned-SuperMogul Kathy Ireland Interviews Anpac Bio CEO For 'WorldwideBusiness' SACRAMENTO, Calif., April 20, 2018 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, was interviewed this week by "Super Model-turned-Super Mogul" Kathy Ireland, for her award-winning ...

Anpac Bio Wins 2018 International ‘BIG Innovation Award’

Sacramento, CA – Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced today that Anpac Bio has won the highly prestigious, international, “2018 BIG Innovation Award”. Recognizing the entire corporation for executing significant and consistent innovation through its ...

Anpac Bio Achieves Milestone of Exceeding Seventy Patents Issued in Twenty Countries/Regions Worldwide

SACRAMENTO, CA | April 16, 2018 –International life sciences and cancer screening technology corporation Anpac Bio-Medical Science Co.,  Ltd. (“Anpac Bio”),  recently achieved a significant milestone of receiving over seventy patents issued in twenty major countries throughout the world. Anpac Bio’s CEO, Dr. Chris Yu, has ...

Anpac Bio Revenue Surges Nearly 300% After Signing 15th Global Fortune 500 Company Customer

SACRAMENTO, Calif., May 21, 2018  -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, confirmed the company's 2018 revenue vaulted nearly 300% over Anpac Bio's 2017 revenue of the same period, immediately following news reports that Anpac Bio successfully secured its 15th global Fortune ...

Anpac Bio’s Liquid Biopsy Tests Catch 26+ Early-Stage Cancers in Single Blood Test!

SACRAMENTO, Calif., Feb. 7, 2018 /PRNewswire/ -- Anpac Bio-Medical Science Company (Anpac Bio), and its internationally-acclaimed medical research partners, are celebrating  "National Cancer Prevention Day" (#NationalCancerPreventionDay – February 7, 2018) by confirming a new, global milestone: Anpac Bio's proprietary "Cancer Differentiation Analysis" (CDA) liquid biopsy technology now identifies over 26 ...

Anpac Bio Surpasses 100 Case Milestone Detecting Disease in Patients Deemed ‘Cancer Free’ by Traditional Screening

SACRAMENTO, Calif., Dec. 27, 2017 -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced this week surpassing a new, international record. Anpac Bio's breakthrough, proprietary, "Cancer Differentiation Analysis" (CDA) liquid biopsy technology identified the earliest cancer and pre-cancerous disease signals in over 100 individuals ...

Anpac Bio Wins Global Precision Medicine Industry Award: 2017 ‘Most Promising Cancer Screening Company’

SACRAMENTO, Calif., July 17, 2017 —The Global Precision Medicine Industry Awards leadership named international life sciences corporation Anpac Bio-Medical Science Co., Ltd. ("Anpac Bio"), the 2017, "Most Promising Cancer Screening Company" award winner; in recognition of Anpac Bio's proprietary, "Cancer Differentiation Analysis" (CDA) liquid biopsy cancer screening and diagnostic support services. Citing ...

Anpac Bio Surpasses 40,000 Case Study Milestone ‘Liquid Biopsy Pioneer’ Serving Individual, Medical, Insurance & Corporate Customers.

SACRAMENTO, Calif., March 28, 2017 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced this week the company set a new, international record, processing and reporting over 40,000 cases worldwide of the company's proprietary, "Cancer Differentiation ...